Lipid‐lowering response of the HMG‐CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low‐density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia

Although the efficacy of fluvastatin (HMG‐CoA reductase inhibitor) in the treatment of primary hypercholesterolemia is well documented, a wide interindividual variation treatment response has been observed. We have studied the possible role of the AvaII (exon 13), HincII (exon 12), and PvuII (intron...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Lab Anal
Hlavní autoři: Salazar, Luis A., Hirata, Mario H., Quintão, Éder C.R., Hirata, Rosario D.C.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2000
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6807834/
https://ncbi.nlm.nih.gov/pubmed/10797611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/(SICI)1098-2825(2000)14:3<125::AID-JCLA7>3.0.CO;2-S
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky